arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Drugs Made In America Acquisition II Corp.

DMII
$10.11 0.00 (0.00%) at close
Financials ·Blank Checks ·USBlank Checks
2 Visible periods
11 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Neutral
auto_awesome

Analytical Summary

Drugs Made In America Acquisition II Corp. shows mixed fundamentals. Consider comparing against peers in the Financials sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC 2.2%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Jul 31, 2026.

Health Breakdown

Returns
26
Cash Quality
16

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 2 years · 7 quarters